Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.24.59 (
MIP
)
4,906
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We previously demonstrated that
PACRG
plays a role in regulating dynein-driven microtubule sliding in motile cilia. To expand our understanding of the role of
PACRG
in ciliary assembly and motility, we used a combination of functional and structural studies, including newly identified
Chlamydomonas pacrg
mutants. Using cryo-electron tomography we show that
PACRG
and FAP20 form the inner junction between the A- and B-tubule along the length of all nine ciliary doublet microtubules. The lack of
PACRG
and FAP20 also results in reduced assembly of inner-arm dynein IDA
b
and the beak-
MIP
structures. In addition, our functional studies reveal that loss of
PACRG
and/or FAP20 causes severe cell motility defects and reduced in vitro microtubule sliding velocities. Interestingly, the addition of exogenous
PACRG
and/or FAP20 protein to isolated mutant axonemes restores microtubule sliding velocities, but not ciliary beating. Taken together, these studies show that
PACRG
and FAP20 comprise the inner junction bridge that serves as a hub for both directly modulating dynein-driven microtubule sliding, as well as for the assembly of additional ciliary components that play essential roles in generating coordinated ciliary beating.
...
PMID:PACRG and FAP20 form the inner junction of axonemal doublet microtubules and regulate ciliary motility. 3111 84